<WIRE> ECS Botanics Reports Q1 Revenue of A$4.1 Million

Monday, 16 October 2023

ECS Botanics (ASX:ECS) reported a Q1 revenue of A$4.1 million.

This figure represents a significant increase of 78% as the company experiences a sharp rise in the demand for their medicinal cannabis oils.

Beginning FY24 with strong momentum and a burgeoning portfolio of off-take agreements and orders, ECS Botanics appears poised for sustained growth.

ECS Botanics (ASX:ECS) is a industry-leading cannabis company specializing in medicinal applications.

Supported by

<SPON> Trade share CFDs with Plus500

Apr 4, 2022

Global online trading services company, Plus500:

Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.

Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.

LINK

Subscribe to the newsletter

Receive whispers every day in your inbox.